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Abstract
Bacterial populations co-ordinate gene expression collectively through quorum sensing (QS), a cell-to-cell communication
mechanism employing diffusible signal molecules. The LysR-type transcriptional regulator (LTTR) protein PqsR (MvfR) is a
key component of alkyl-quinolone (AQ)-dependent QS in Pseudomonas aeruginosa. PqsR is activated by 2-alkyl-4-quinolones
including the Pseudomonas quinolone signal (PQS; 2-heptyl-3-hydroxy-4(1H)-quinolone), its precursor 2-heptyl-4-
hydroxyquinoline (HHQ) and their C9 congeners, 2-nonyl-3-hydroxy-4(1H)-quinolone (C9-PQS) and 2-nonyl-4-hydroxyquino-
line (NHQ). These drive the autoinduction of AQ biosynthesis and the up-regulation of key virulence determinants as a
function of bacterial population density. Consequently, PqsR constitutes a potential target for novel antibacterial agents
which attenuate infection through the blockade of virulence. Here we present the crystal structures of the PqsR co-inducer
binding domain (CBD) and a complex with the native agonist NHQ. We show that the structure of the PqsR CBD has an
unusually large ligand-binding pocket in which a native AQ agonist is stabilized entirely by hydrophobic interactions.
Through a ligand-based design strategy we synthesized and evaluated a series of 50 AQ and novel quinazolinone (QZN)
analogues and measured the impact on AQ biosynthesis, virulence gene expression and biofilm development. The simple
exchange of two isosteres (OH for NH2) switches a QZN agonist to an antagonist with a concomitant impact on the
induction of bacterial virulence factor production. We also determined the complex crystal structure of a QZN antagonist
bound to PqsR revealing a similar orientation in the ligand binding pocket to the native agonist NHQ. This structure
represents the first description of an LTTR-antagonist complex. Overall these studies present novel insights into LTTR ligand
binding and ligand-based drug design and provide a chemical scaffold for further anti-P. aeruginosa virulence drug
development by targeting the AQ receptor PqsR.
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Introduction
Bacterial cells communicate with each other through quorum
sensing (QS), a mechanism for co-ordinating gene expression at
the population level via the release and detection of self-generated
signalling molecules [1]. Once a critical threshold concentration of
QS signal has been attained, a change in collective behavior
ensues through the activation of a sensor or regulator protein. In
general, QS facilitates the coordination of population behavior to
enhance access to nutrients, provide collective defense against
other competitor organisms or to encourage community escape
where population survival is at risk [1]. QS signal molecules are
chemically diverse and include both small peptides and organic
molecules such as the N-acylhomoserine lactones (AHLs) and 2-
alkyl-4(1H)-quinolones (AQs). In addition, many bacteria possess
several interacting QS modules organized into regulatory hierar-
chies employing multiple signal molecules from the same or
different chemical classes. Such QS hierarchies regulate motility
and biofilm development, secondary metabolite production,
bioluminescence and virulence [1]. With respect to the latter,
the global emergence of multi-antibiotic resistant bacteria and the
paucity of new clinically effective antibiotics have renewed interest
in the development of agents which control infection through the
attenuation of bacterial virulence rather than inhibition of growth
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[2], [3]. In this context, the QS-dependent regulation of virulence
offers an attractive suite of potential targets which include the QS
signal synthase, the response regulator and the QS signal molecule
itself [4], [3].
While there have been extensive attempts to unravel the
molecular basis for AHL-dependent QS and to develop inhibitors
directed against LuxR-type transcriptional regulators, there is
relatively little structural information on the recognition and
mechanism of action or inhibition of AQ-type QS signals. AQs are
produced by pathogens such as Burkholderia pseudomallei and
Pseudomonas aeruginosa [5], [6]. P. aeruginosa thrives in diverse
ecological niches and causes both acute and chronic infections in
humans, animals, plants and insects. Multi-antibiotic resistant
strains have emerged globally as a major cause of hospital-
acquired infections for which current therapeutic options are very
limited [7]. P. aeruginosa produces diverse exotoxin virulence
determinants and secondary metabolites including cyanide, readily
forms biofilms and is naturally resistant to many antimicrobial
agents. Since many of these virulence genes are controlled by QS
[8], P. aeruginosa has emerged as a paradigm pathogen since it
employs a sophisticated multi-signal QS system incorporating both
AHL/LuxR type and AQ-dependent gene regulatory systems [8]
(Figure 1). With respect to the AQs, P. aeruginosa produces over 50
different congeners which were originally identified via their
antimicrobial properties but are now known to possess QS,
immune modulatory, cytochrome inhibitory, metal chelating,
membrane vesicle-stimulating and oxidant activities (reviewed in
[9]).
2-Heptyl-3-hydroxy-4(1H)-quinolone (the ‘Pseudomonas Qui-
nolone Signal’, PQS) and its immediate precursor, 2-heptyl-4-
hydroxyquinoline (HHQ) are frequently considered to be the
primary AQs involved in QS although other active AQ analogues,
notably the C9 congeners, 2-nonyl-3-hydroxy-4(1H)-quinolone
(C9-PQS) and 2-nonyl-4-hydroxyquinoline (NHQ) are produced
by P. aeruginosa in similar concentrations [10], [11]. The synthesis
and action of PQS and HHQ and related congeners depends on
the pqsABCDE operon, which is positively controlled by the
transcriptional regulator PqsR (MvfR) [12], [13]. The first four
gene products of this operon are required for AQ biosynthesis [9].
HHQ is released into the extracellular milieu where it is
internalized via adjacent cells [14] and oxidized to PQS via the
action of the mono-oxygenase PqsH [5], [13], [15]. The function
of the pqsE gene product, a putative metallohydrolase, is not
currently understood. Although it does not contribute to AQ
biosynthesis, it is required for swarming motility biofilm develop-
ment and virulence and is involved in the negative regulation of
the pqsABCDE operon [15], [16]. Strains with mutations in pqsR
and pqsA are severely attenuated in experimental animal infection
models highlighting the important contribution made by AQ
signalling to pathogenicity [16], [12]. Furthermore the presence of
AQs in the sputum and broncho-alveolar lavage fluid of cystic
fibrosis patients chronically infected with P. aeruginosa provides
evidence of their importance in human infection [17], [18].
AQ synthesis and pqsE expression are subject to a positive
feedback loop which involves the activation of PqsR by HHQ and
PQS and their C9 congeners to drive the expression of the
pqsABCDE operon [14], [19], [20], [21], [22]. In whole P.
aeruginosa cell assays, HHQ and PQS exhibited EC50s in the low
micromolar range for the PqsR-dependent activation of pqsA [23].
Activation of PqsR depends on the AQ alkyl chain length [23],
PQS congeners with C1, C3, C5 or C11 alkyl chains exhibit only
weak activities compared with the C7 compounds. However, the
C9 congeners, 3-hydroxy-2-nonyl-4(1H)-quinolone (C9-PQS) and
2-nonyl(1H)-4-hydroxyquinoline (NHQ) are highly active [23].
Although both HHQ and PQS can activate PqsR, the PqsH-
mediated introduction of a hydroxyl group at the 3 position of the
quinolone ring confers additional physicochemical functionality to
PQS over HHQ including iron chelation [14] and microvesicle
formation [24].
Attempts to attenuate AQ signaling and the virulence of P.
aeruginosa without perturbing bacterial growth have so far mainly
focused on enzymes which inactivate PQS [25] and methylated or
halogenated derivatives of the AQ precursor anthranilate such as
2-amino-4-chorobenzoic acid (4-CABA) which inhibits AQ
biosynthesis probably at the level of PqsA by competing with
anthranilate for the enzyme active site [26], [27]. This approach
has recently shown promising results in limiting the systemic
proliferation of P. aeruginosa infection in mice although the
concentrations required to inhibit AQ production were high
(millimolar range; [27]) and so unlikely to be clinically useful.
More recently a number of PqsD inhibitors have been identified
[28].
An alternative approach for blocking AQ biosynthesis and
signalling and hence virulence would be to target the response
regulator PqsR. Although the structures of the PqsR-activating
ligands PQS and HHQ are known (Figure 2), there is no
information on the PqsR ligand binding site. PqsR belongs to the
LysR family of transcriptional regulators (LTTRs) which are
widespread in bacteria [29] among which P. aeruginosa appears to
have one of the largest repertoires [30]. LTTR proteins generally
possess a highly conserved N-terminal helix-turn-helix (HTH)
DNA-binding domain but a poorly conserved C-terminal ligand-
binding domain usually termed the co-inducer binding domain
(CBD) where the co-inducer is a low molecular weight ligand [29].
LTTRs function as either activators or repressors in feedback
loops in which the co-inducer ligand is required for transcriptional
control. LTTR proteins are generally thought to function as
tetramers recognizing multiple binding sites within the promoter/
operator region of the target gene(s) which include a regulatory
binding site (RBS) incorporating the LTTR box (general
consensus T-N11-A) and an activation binding site (ABS).
Occupation of these sites results in DNA bending and contact
with RNA polymerase to initiate transcription [29]. Structural
Author Summary
Populations of bacterial cells collectively co-ordinate their
activities through cell-to-cell communication via the
production and sensing of signal molecules. This is called
quorum sensing (QS) and in many bacteria, QS controls the
expression of virulence genes, the products of which
damage host tissues. Consequently, QS systems are
potential targets for antimicrobial agents which do not
kill bacteria but instead block their ability to cause disease.
Pseudomonas aeruginosa causes a wide range of human
infections and produces an armoury of virulence factors.
Since many of these are controlled by alkylquinolone (AQ)-
dependent QS, we determined the crystal structure of the
AQ receptor (PqsR) in order to visualize the shape of the
AQ-binding site and better design PqsR inhibitors which
compete for the AQ binding site and so block QS. This
work in conjunction with the chemical synthesis of AQ
analogues resulted in the discovery of potent quinazoli-
none inhibitors of PqsR. These blocked AQ and virulence
factor production in P. aeruginosa as well as biofilm
development. Our studies present novel insights into the
structure of PqsR and create further opportunities for
target-based antibacterial drug development.
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Figure 1. Diagrammatic representation of the AQ-dependent QS network in Pseudomonas aeruginosa. The PqsABCD proteins synthesize
HHQ, which is converted to PQS by PqsH. Autoinduction occurs when either HHQ or PQS binds to PqsR and amplifies expression of the pqsABCDE
operon. The terminal output of this regulatory network is PqsE, a putative metallohydrolase protein of unknown enzymatic function which positively
regulates virulence genes, secondary metabolites and biofilm development when expressed in the absence of HHQ and PQS. The PqsE regulatory
pathway also downregulates pqsA and AQ biosynthesis. The conversion of HHQ to PQS confers additional functionalities since PQS unlike HHQ
induces microvesicle formation and is a potent iron chelator which induces expression of the pyoverdin and pyochelin high affinity iron transport
systems. AQ-dependent QS is closely linked to the AHL-dependent las and rhl QS systems. The las system positively regulates the transcription of
pqsR, pqsABCDE and pqsH while rhl exerts a negative effect on the AQ system, although it is itself positively regulated by AQs. Filled arrows and
blunted lines represent positive and negative regulation, respectively.
doi:10.1371/journal.ppat.1003508.g001
Figure 2. Activation and inhibition of PqsR in P. aeruginosa by the 2-alkyl-4(1H)-quinolones. *EC50 determined in a P. aeruginosa DpqsA
CTX::pqsA’-lux strain; **EC50 determined in a P. aeruginosa DpqsAH CTX::pqsA’-lux strain; – no activity.
doi:10.1371/journal.ppat.1003508.g002
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studies of LTTRs have been mostly restricted to the C-terminal
CBD because of the insolubility associated with the HTH domain
[29]. LTTR CBDs typically have two a/b sub-domains (CBDI
and CBDII) connected by an anti-parallel b-sheet known as the
hinge region [31], [32]. Well characterised ligands for LTTRs
include catechols and chlorinated aromatics which are co-inducers
for CatM and BenM respectively binding into a pocket between
the CBD subdomains [29].
With respect to PqsR, how this unusual LTTR [30] recognizes
and responds to the larger hydrophobic ligands associated with
AQ-dependent QS is not known. The structural basis for the
recognition of AQs by PqsR has not been elucidated and there is
consequently a lack of molecular detail to facilitate the develop-
ment of PqsR inhibitors as novel therapeutics. Through a
multidisciplinary effort we provide new insights into the structure
of the PqsR co-inducer binding domain (PqsRCBD) in complex
with both a native AQ agonist and a potent quinazolinone (QZN)
antagonist. The QZN scaffold was evolved through ‘ligand based
design’ and we show that in P. aeruginosa a very simple isosteric
replacement is sufficient to switch a QZN from potent agonist to
potent antagonist turning QS-dependent virulence gene expres-
sion on or off respectively. Although other LTTR agonist complex
structures have been described this, to our knowledge, is the first
description of an LTTR-antagonist complex crystal structure.
Results
Structure of the PqsR Co-inducer Binding Domain
To investigate the molecular basis of PqsR ligand recognition
we first sought to determine the crystal structure. The full length
PqsR receptor containing both the DNA-binding domain and
CBD was insoluble when expressed in Escherichia coli. We thus
focused on a construct spanning C-terminal residues 94-332
incorporating the CBD (Figure 3A). This was soluble and was
utilised for initial crystallisations together with a truncated version
which removed the 23 amino acid C-terminal tail. Crystals were
obtained only in conditions where the precipitant, 2-methyl-2,4-
pentanediol (MPD) was present and the structure was determined
using SAD and SIR phases in spacegroup P6522 to 2.5 A˚
resolution (Table 1). Crystallisation of the PqsRCBD has been
reported previously by two groups at 5 A˚ [33] and 3.25 A˚
resolution respectively [34]. The latter P6522 crystal form has
Figure 3. Crystal Structure of the PqsRCBD. (A) Diagrammatic representation of the linear PqsR protein showing the positions of the DNA-
binding (DBD) and co-inducer-binding (CBD) domains; (B) Topology diagram of the PqsRCBD monomer consisting of two sub-domains and a hinge
region; (C) PqsRCBD hydrophobic ligand-binding pocket with two bound MPD molecules shown as purple sticks; (D) Charged surface representation
of the A and B pockets shown as two views related by a 180u rotation. Hydrogen bonds are shown as dotted lines and water molecules as red
spheres; (E) The PqsRCBD dimer shown as a topology diagram with bound MPD molecules shown as sticks. Loops forming a lid are coloured red and
blue. The Lys266 and Glu259 residues are shown as sticks with the salt bridge shown as a purple dotted line. The pocket shape is shown as a white
mesh. (F) The PqsRCBD dimer shown as solid spheres with the same colour scheme.
doi:10.1371/journal.ppat.1003508.g003
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similar cell dimensions to the crystal form reported here although
the crystallisation conditions differ and MPD is not present. The
construct reported in Xu et al. [34] has different domain
boundaries spanning residues 91–319 compared to residues 94–
294 and 94–332 reported here.
The PqsRCBD structure has one molecule in the crystallographic
asymmetric unit. Analytic gel filtration was performed with a
calibrated Superdex 75 10/300 column revealing the recombinant
PqsRCBD eluted close to the 43 kDa marker (ovalbumin) and
above the 29 kDa marker (carbonic anhydrase) (Figure S1A). As
the calculated monomer molecular weight for PqsRCBD is
22.7 kDa this indicates a dimeric species is present in solution.
This is in agreement with the gel filtration data for the PqsRCBD
reported by Xu et al. [34].
The topology of the PqsRCBD structure is illustrated in
Figure 3B showing two subdomains (CBDs I and II) connected
by an antiparallel b-sheet termed the hinge region as observed in
related LTTR structures of BenM and CatM [35], [36]. Overall,
CBDI is similar to other LTTRs with the exception of helix a2
which is shorter in PqsR. In CBDII a number of large changes are
observed as a helix present in BenM between strands b5 and b6 is
absent and replaced by an irregular loop structure (L1) lying at the
junction of the two subdomains. The hinge region also adopts a
different conformation in PqsRCBD and the b4, b8 antiparallel
strands are repositioned closer to the C-terminal helix. These two
changes of a helix removal and the repositioning of the hinge
region effectively open up the CBDII structure to form a large
hydrophobic pocket occupied by two MPD molecules
(Figures 3C and 3D).
MPD molecule 1 (MPD1) is highly buried, surrounded by
aliphatic residues (Leu, Ile, Ala) from both sub-domains and a
water mediated interaction with the carbonyl group of Ile236 at
the bottom of the pocket (termed the B pocket, Figure 3D).
MPD2 is predisposed closer to the surface in CBDII interacting
with the side chains of Tyr258 and Val211 (the A pocket,
Figures 3C and 3D).
We examined the crystal lattice and a large dimer interface was
observed with a buried surface area of 1232 A˚2 (topology shown
in Figure 3E). A feature of the dimer is that it presents the two
CBDII pockets on the same surface by aligning the two hinge
regions which interact at either end of strands b4 and b8 forming
contacts. At the centre, the b4 side chain Lys266 is fully extended
forming a salt bridge to Glu259 close to the dimer axis. Further
interfacial contacts occur between helices a3 and a6 at either end
of the dimer (Figure 3E). A second feature is the two
interlocking loops which form a lid partially covering the MPD
molecules (lid loops L1 and L2 shown in red and blue respectively
in Figure 3F). The pocket in each monomer connects across the
Table 1. Crystallographic data collection and refinement statistics.
Sample PqsR native MPD PqsR – K2PtCl4 PqsR – Se-Met PqsR – NHQ
PqsR – 3NH2- 7Cl-
C9QZN
Space group Unit Cell (A˚) P6522 P6522 P6522 P6522 P6522
a 119.7 118.95 119.33 120.43 118.4
b 119.7 118.95 119.33 120.43 118.4
c 115.8 115.63 115.81 115.43 115.4
Wavelength 0.9770 1.07112 0.97930 0.97630 0.97625
Unique reflections 17339 6586 6560 11482 11028
Resolution (A˚) 2.5 3.48 3.5 2.9 2.95
I/Sigma* 22.4 (2.0) 20.1 (6.9) 20.5 (3.4) 17.6 (2.5) 16.0 (2.0)
Rmergea 0.044 (0.740) 0.067 (0.219) 0.071 (0.238) 0.065 (0.830) 0.069 (0.780)
Completeness (%) 99.2 (99.9) 99.9 (100) 99.8 (100) 99.7 (100) 99.4 (100)
Multiplicity 7.9 (8.1) 10.2 (9.0) 20.5 (21.4) 10.4 (10.9) 7.1 (7.5)
CC 1/2b 1 (0.88) - - 1 (0.914) 0.999 (0.894)
Refinement
Rcrystc 22.1 - - 20.5 21.3
Rfreec 26.7 - - 26.5 27.3
Overall B factor (A2) 60.8 - - 80.1 57.1
RMS deviation
Bond Length (A˚) 0.016 - - 0.021 0.019
Bond Angles (u) 2.170 - - 2.201 2.197
PDB code 4JVC - - 4JVD 4JVI
Ramachandran plot
Most favoured 197 - - 197 196
Allowed 4 - - 4 5
*Values in parentheses are for highest-resolution shell.
aRmerge =Sh Si|Ii(h)2,I(h)./|Sh Si Ii(h), where I is the observed intensity and ,I. is the average intensity of multiple observations from symmetry-related reflections
calculated with XDS.
bCorrelation co-efficient value calculated using XDS to determine the resolution cutoff.
cAll values calculated using REFMAC. Rwork =Sh||Fo|h2|Fc|h|/Sh|Fo|h, where Fo and Fc are the observed and calculated structure factors, respectively. Rfree computed as
in Rwork, but only for (5%) randomly selected reflections, which were omitted in refinement.
doi:10.1371/journal.ppat.1003508.t001
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dimer interface via a narrow channel shown as mesh in
Figure 3E.
A second crystallographic dimer interface occurs in the PqsR
lattice which buries a smaller surface area (614 A˚2). This involves
an antiparallel b-sheet formed by strand b2 as well as antiparallel
packing of the two N-terminal a1 helices (Figure S1B). One side
of the interface consists of hydrogen bonds from the b-sheet and
sidechain-sidechain interactions from symmetry related Ser123
side chains (Figure S1 C and D). The residue Ser112 side chains
from helix a1 form a similar side chain hydrogen bond close to the
dimer axis. In the centre, hydrophobic contacts come from
residues above and below the b-sheet (Figure S1 C and D).
PqsR Co-inducer Interactions
We next sought to determine how the PqsRCBD recognises a
naturally occurring AQ co-inducer. As the PqsRCBD lattice has a
high solvent content (72%) we performed crystal soaking
experiments with the most active native ligands produced by P.
aeruginosa namely HHQ, NHQ (C9-HHQ), PQS and C9-PQS
(Figures 2 and 4A) as well as shorter carbon chain length
derivatives. For the majority of these experiments, a calculation of
difference (Fo-Fc) maps resulted in the characteristic electron
density for two MPD molecules occupying the PqsRCBD pocket
and no evidence of a bound ligand (Figure S2A). By contrast the
soaking of NHQ for 24 h resulted in elongated and connected
electron density spanning the two sub-pockets (Figure S2B). The
electron density in the deeper B pocket was observed to be planar
in shape and model building allowed fitting of the quinolone
moiety of NHQ in one unique orientation. The alkyl chain can be
modelled extending into the remaining cigar shaped electron
density to occupy the A pocket. The Tyr258 side chain pins the
alkyl chain down against side chains from residues Ile186, Val170,
Leu189, Ile236 from the bottom and sides of the A pocket forming
a comfortable fit (Figures 4B and 4C). The bicyclic ring
structure is enclosed on either side in the B pocket by contacts
from Leu207, Leu208 and Ile236. From above, contacts come
from Ile149 and Ala168 and from below the sidechain of Phe221
(Figure 4B).
Figure 4. 2-Alkyl-4-quinolone interactions with PqsR. (A) Structures of 2-heptyl-3-hydroxy-4(1H)-quinolone (PQS), 2-heptyl-4(1H)-quinolone (2-
heptyl-4-hydroxyquinoline, HHQ) and 2-nonyl-4(1H)-quinolone (2-nonyl-4-hydroxyquinoline, NHQ); (B) A stereo diagram of the topology of the
PqsRCBD-NHQ complex showing the ligand as stick (yellow). The quinolone ring is buried within the B pocket and the alkyl chain bound to the more
surface accessible A pocket; (C) Charge surface representation of the PqsRCBD showing the hydrophobic pocket occupied by NHQ. The colours
represent acidic (red) and basic (blue) residues; (D) Ligplot schematic diagram showing PqsR hydrophobic contacts with NHQ (within a 3.9 A˚ radius);
(E) Superposed PqsRCBD-NHQ (yellow) and PqsRCBD-MPD (purple) structures shown as stick.
doi:10.1371/journal.ppat.1003508.g004
PqsR Ligand Recognition and Inhibition
PLOS Pathogens | www.plospathogens.org 6 July 2013 | Volume 9 | Issue 7 | e1003508
The fit of the bicyclic ring into the B pocket is not precise and
beneath the carbonyl and in front of the aliphatic ring two vacant
sub-pockets are present. A surprising feature of the structure is that
the interactions are all hydrophobic with the absence of any
hydrogen bonds or electrostatic interactions to the NHQ carbonyl
oxygen or NH group of the bicyclic ring (Figure 4D). Although
the interactions with NHQ are exclusively hydrophobic, modelling
of the additional OH present in the alternative co-inducer, PQS,
reveals this group could potentially form an additional contact
through a hydrogen bonding interaction with the carbonyl group
of Leu207.
Superposition of the PqsRCBD-NHQ with the PqsRCBD-MPD
structure reveals subtle local conformational changes in the
binding pocket (Figure 4E). The Thr265 side-chain rotates by
180u to make a direct contact with NHQ and a concomitant 0.7 A˚
movement of the main chain affects a similar movement in the
position of the adjacent residue Asp264 in the hinge region
affecting strands b4 and b8 (Figure 4E).
Probing PqsRCBD Ligand Binding by Site-Directed
Mutagenesis
To probe the contribution of the key PqsRCBD amino acid
residues identified above (Figure 4B) to AQ binding, 13 site-
specific substitutions were introduced into a 6His-tagged PqsR
which retains activity in P. aeruginosa (Figure 5A). PqsR mutant
functionality was evaluated by (i) Western blot to confirm PqsR
expression (Figure 5C) and (ii) the ability to restore pqsA
expression in the P. aeruginosa DpqsR miniCTX::pqsA’-lux reporter
strain (Figure 5B). Each of the pqsR mutations altered pqsA
promoter activity with mild reductions observed for three
mutations Ile186Ala, Ile236Phe and Leu207Glu which exhibited
44.1%, 20.5% and 13.7% of the wild-type PqsR-6His, respectively
(Figure 5B). In the PqsRCBD structure, Ile186 is positioned at the
far end of the A pocket and substitution by Ala removes the side
chain atoms which contact the end of the alkyl chain; a loss of this
contact would be predicted to reduce the interaction with the A
pocket. Ile236 is positioned at the bottom of the A pocket lying at a
boundary with the B pocket. It is fully buried by bound NHQ in
the complex structure making contacts between its side chain
atoms and the planar surface of the bicyclic ring. Mutation to Phe
would be predicted to disrupt binding by introducing extra volume
and changing the shape of the pocket. Leu207 is positioned on the
side of the B pocket and interacts with NHQ at the junction
between the alkyl chain and the bicyclic ring through its terminal
side chain atom. The Leu207Ala and Leu207Glu mutations both
result in a ,10% response compared with wild type indicating
that the altered size and charge similarly affect optimal ligand
contacts. An almost complete loss of activity (,2% of that of the
wild type) is observed for four mutations (Ile149, Phe221, Tyr258,
Ile263). As we are unable to purify a soluble form of the full length
wild type or mutant PqsR variants we could not rule out whether
these four mutations have an effect by disrupting protein folding
rather than ligand binding. Furthermore, we also observed that
the PqsRCBD protein precipitates in the presence of its highly
hydrophobic ligands even at dilute protein concentrations (a
finding also noted by Xiao et al., [21]) making alternative
biophysical approaches difficult.
Using a P. aeruginosa DpqsA DpqsH DpqsR triple mutant which
does not produce endogenous AQs and containing a chromo-
somally-integrated miniCTX::pqsA’-lux reporter, we examined the
response of the PqsR-6His variants to PQS and HHQ. The data
presented in Figure 5D shows that the variants exhibited reduced
responses to PQS and HHQ, consistent with the data in
Figure 5B. However, the degree of response was significantly
different for the two co-inducers, with PQS giving a consistently
higher response, e.g. the Leu207Glu mutation responded much
more poorly to HHQ (5%) than to PQS (39%). This observation is
consistent with the notion that the additional 3-OH group of PQS
can potentially form a hydrogen bond to the main chain carbonyl
of Leu207 and thus it may not rely as heavily as HHQ/NHQ on
the side chain interaction with Leu207 which is altered in this
mutant.
Synthesis and Evaluation of QZNs as PqsR Antagonists
To conserve the steric requirements for optimal ligand/receptor
interactions, antagonists have frequently been discovered through
structural modification of native agonists. Hence we used the
closely related 2-alkyl-4(3H)-quinazolinone (QZN) system as a
template to probe structure-activity relationships (SARs). We
focused on QZN analogues with C7 or C9 alkyl side chains as AQ
congeners with C5 or C11 have little activity ([23]). A series of 42
variously substituted QZNs (Figure 6) was synthesized and
characterized as described in Text S1 and the corresponding
EC50s and IC50s for each compound determined via dose–
response curves generated using PqsR-dependent P. aeruginosa
miniCTX::pqsA’-lux reporter gene fusion assays. For comparative
purposes, Figure 2 summarizes the EC50 data obtained for PQS,
HHQ and their corresponding C9 congeners, NHQ and C9-PQS
in both P. aeruginosa DpqsA and P. aeruginosa DpqsAH mutant
backgrounds since both HHQ and NHQ can be converted to the
corresponding 3-hydroxy compound by the mono-oxygenase,
PqsH [15]. Figure 2 shows that the 4 co-inducers have similar
EC50s in P. aeruginosa.
The SAR data for the QZNs is summarized in Figure 6. C7-
QZN and C9-QZN (Figure 6, 7 and 8) which are 3-aza
analogues of HHQ and NHQ respectively, and 7F-C9-QZN
(Figure 6, 8), all of which lack a substitution in the 3-position,
were devoid of agonist or antagonist activity. Hydroxylation at the
3-position of C7-QZN and C9-QZN gave compounds (Figure 6,
9 and 10) which were substantially weaker agonists than PQS.
These agonist properties were substantially improved by the
introduction of a halogen substituent at the 7-position of the
carbocyclic ring as in 3-OH-7Cl-C9-QZN and 3-OH-7F-C9-
QZN (Figure 6, 11 and 12). However the 3-methoxy variants, 3-
OMe-C7-QZN and 3-OMe-C9-QZN (Figure 6, 13 and 14) were
inactive unless halogenated at C-7 (Figure 6, 15 and 16). In this
QZN series, 3-OMe-7F-C9-QZN (Figure 6, 16) was as potent an
agonist as PQS. Introduction of a second fluorine to give 3-OMe-
6F,7F-C9-QZN reduced potency by ,25-fold (Figure 6, 17)
To explore the QZN SAR further and to identify an essential
pharmacophore for antagonist activity, we replaced the 3-OH
group with the isosteric 3-NH2 group in the above derivatives and
synthesized 3NH2-C7-QZN (Figure 6, 19) and its alkyl chain
altered variants (Figure 6, 20, 21, 29–32). None of these
compounds were agonists. This was particularly interesting given
that replacement of the 3-OH in PQS with 3-NH2 (Figure 2, 1
and 5a) results in a compound which is a more potent agonist than
the natural ligand (EC50 0.460.15 mM).
QZNs with branched chains (Figure 6, 29 and 30), unsatura-
tion (Figure 6, 31) or with increased hydrophilicity (Figure 6, 32)
were all inactive while compounds 19, 20 and 21 (Figure 6) were
antagonists, the most potent being 3NH2-C7-QZN (Figure 6, 19;
IC50 54615.5 mM). An attempt to further improve the activity via
the introduction of a 6-Cl substituent in 3NH2-C9-QZN to yield
3NH2-6Cl-C9-QZN (Figure 6, 22) resulted in the complete loss
of antagonist activity but gratifyingly, potency was greatly
increased by a 7-Cl substituent (3-NH2-7Cl-C9-QZN; Figure 6,
23; IC50 561.6 mM). Fluorine substituted derivatives (Figure 6,
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Figure 5. Response of PqsRCBD ligand binding site mutants to AQs. (A) PqsR-6His is functional in P. aeruginosa. The pqsR gene with or
without a 6His tag on pME6032 was introduced into a P. aeruginosa pqsR deletion mutant (DpqsR) containing a chromosomal miniCTX::pqsA’-lux
reporter gene fusion. Relative PqsR activity was determined as a % of the maximum bioluminescence produced by the miniCTX::pqsA’-lux reporter
fusion in a wild type P. aeruginosa PAO1 background carrying the empty pME6032 vector; (B) Light output from the P. aeruginosa DpqsR
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25 and 26) were also antagonists, the most potent compound being
3-NH2-6F,7F-C9-QZN (IC50 1.260.4 mM).
Introduction of an electron withdrawing group CF3 at C-7 as in
3-NH2-7CF3-C9-QZN or 8-aza as in 3-NH2-8aza-C9-QZN
(Figure 6, 27 and 47 respectively) resulted in the complete loss
of activity. The presence of electron donating methoxy substituents
as in 3-NH2-6OMe,7OMe-C9-QZN (Figure 6, 28) also rendered
the compound inactive. Further modification of the 3-NH2 group
of the C9-QZNs by acetylation, dimethylation, or 2-aminoethyla-
tion (Figure 6, 33, 34 and 35 respectively) yielded only inactive or
weak antagonists, the potency of which could be increased as
before by the presence of a Cl at the 6 or 7 position of the
carbocyclic ring (Figure 6, 36 and 37). The 3-(3-aminopropyl)
compound (Figure 6, 38) only showed marginal improvement in
activity. However these compounds (Figure 6, 35–38) also
exhibited growth inhibitory activity and were therefore excluded
from further work given that a primary objective was to obtain
PqsR inhibitors which attenuate P. aeruginosa virulence without
inhibiting growth.
Compounds 39–46 (Figure 6) represent further attempts to
increase antagonist potency through modification of the alkyl side
chain by synthesising derivatives where the alkyl chain is
terminally substituted with aryl (Figure 6, 39–42), heteroaryl,
biaryl or cyclohexyl groups (Figure 6 compounds 43,44,45 and
46) respectively. These QZNs were all inactive apart from the
phenyl substituted compounds 3-C2NH2-7Cl-PhC3-QZN and 3-
NH2-7Cl-PhC3-QZN (Figure 6, 39 and 41) which were weak
antagonists (IC50s 79.262.7 mM and 39.6611 mM respectively).
Structure of the PqsRCBD-3-NH2-7Cl-C9-QZN Complex
To determine whether the QZN antagonists are competitive
inhibitors which interact with the AQ-binding pocket, we first
investigated whether inhibition of PqsR by 3-NH2-7Cl-C9-QZN
could be overcome by increasing concentrations of PQS. The data
are shown in Figure 7A which reveals that PQS above 25 mM
competitively overcomes QZN-mediated PqsR inhibition. To
investigate how the 3-NH2-7Cl-C9-QZN interacts with PqsR
CBD
crystals were soaked in a solution of the compound. The resulting
structure revealed the quinazolinone moiety is buried in the B
pocket with the alkyl chain extending into the A pocket. The QZN
molecule forms very similar hydrophobic interactions with the
pocket noted for NHQ (Figure 7B). In addition, the Cl atom of
the 3-NH2-7Cl-C9-QZN occupies the vacant sub pocket present
in front of the aliphatic ring and forms a hydrogen bond with the
side chain of Thr265 (Figure 7C). The 3-NH2 substituent forms a
hydrogen bond to the main chain carbonyl oxygen of Leu207
(Figure 7 B and D). Superposition of this structure with the
agonist NHQ-PqsRCBD complex reveals differences resulting from
the additional contacts made by the QZN (Figure 7D). This tilts
the QZN bicyclic ring relative to NHQ affecting a subtle
repositioning of the alkyl chain. The QZN interactions affect
small changes in the main chain of the L1 loop and the 7-Cl atom
induces a rotation of the Thr265 side chain rotamer by 90u to
NHQ. In addition, the introduction of the 7Cl substituent into
PQS to generate 7Cl-PQS resulted in an agonist which is ,135
times more potent than PQS itself (Figure 2) providing further
confirmation of the importance of the vacant sub-pocket adjacent
to the Thr265 residue.
QZN Antagonists as Anti-virulence Agents
The QZN antagonists of PqsR were identified on the basis of
their inhibition of pqsA transcription through the competitive
antagonism of the AQ-dependent activation of PqsR. To
determine whether the QZNs could also inhibit the expression
of target virulence genes such as lecA (which codes for the cytotoxic
galactophilic lectin protein LecA, which also contributes to biofilm
development; [37]) and phzA1 (which codes for an enzyme
involved in the biosynthesis of the redox-reactive phenazine
pigment pyocyanin; [38]), we constructed lecA-lux and phzA1-lux
reporter gene fusions integrated in the chromosome of wild type P.
aeruginosa PAO1. Since lectin A and pyocyanin production depend
on pqsE expression [16], which in turn requires the PqsR-
dependent activation of the pqsABCDE operon, inhibitors of PqsR
should result in the down-regulation of lecA and phzA expression.
Compared with the control, the expression of lecA is reduced by 3-
NH2-7-Cl-C9-QZN (Figure 8A). Similar results were obtained
with the phzA1 promoter for which 12.5 mM 3-NH2-7Cl-C9-QZN
reduced activity by,50% (data not shown). In agreement with the
findings for the phzA1 promoter, pyocyanin levels were also
substantially reduced in P. aeruginosa cultures treated with the QZN
(Figure 8B). These data are consistent with a reduction in AQ
levels and LC-MS/MS analysis of P. aeruginosa cultures grown in
the presence of 3-NH2-7Cl-C9-QZN shows that the production of
HHQ, NHQ, their corresponding N-oxides as well as PQS are
reduced to very low levels (Figure 8C). Since AQ-dependent QS
also contributes to biofilm maturation we examined the impact of
3-NH2-7Cl-C9-QZN on biofilm development under flow condi-
tions using a microfluidics device. Representative confocal
microscope images of the green fluorescent protein (GFP)-tagged
P. aeruginosa wild type grown in the presence or in the absence of 3-
NH2-7Cl-C9-QZN, and of the P. aeruginosa DpqsA mutant strain
are shown in Figure 8D. In common with the DpqsA mutant, 3-
NH2-7Cl-C9-QZN-treated wild type biofilms exhibited reduced
surface area coverage. This is consistent with previous reports on
reduced biofilm formation in P. aeruginosa pqsA mutants, primarily
as a result of a reduction in the release of extracellular DNA, an
important constituent of the extracellular matrix which is released
via a process that requires PQS [39], [40].
Discussion
Understanding the molecular recognition of AQs has important
implications for gaining insight into the molecular basis of the
PqsR receptor ligand and inhibitor interactions. We determined
the crystal structure complex of the PqsRCBD domain with native
agonist and synthetic antagonist ligands. This revealed a core
structure similar to that of other LTTR proteins incorporating two
sub-domains (CBDI and CBDII). Among LTTR proteins, the
CBD domains have the same overall topology despite little
sequence similarity [36]. However, in contrast to other LTTRs,
where a small primary ligand-binding pocket is located in the cleft
between the two sub-domains [35], the PqsR ligand binding site is
larger extending into CBDII as well as occupying a large B pocket
miniCTX::pqsA’-lux strain transformed with one of each of the 13 site-specific mutations introduced into the PqsRCBD ligand-binding pocket.
Bioluminescence is presented as % of pqsA promoter activity with respect to PAO1 DpqsR miniCTX::pqsA’-lux expressing the PqsR-6His protein (WT);
(C) Western blot analysis confirming expression of each of the PqsR-6His mutant proteins; (D) Light output from the P. aeruginosa DpqsA DpqsH
DpqsR miniCTX::pqsA’-lux strain transformed with either the gene coding for PqsR-6His or one of the 13 site-specific mutants and supplemented with
either HHQ or PQS (40 mM). Bioluminescence is presented as % of pqsA promoter activity with respect to the P. aeruginosa DpqsA DpqsH DpqsR
miniCTX::pqsA’-lux strain expressing PqsR-6His.
doi:10.1371/journal.ppat.1003508.g005
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between CBDI and CBDII (Figure S3). This pocket is partially
covered by lid loops upon formation of a large dimer interface. A
central antiparallel dimer organisation is common among LTTR
crystal structures, however these are formed between the ‘cleft’
side of the monomer whereas the PqsRCBD dimer is formed from
the hinge region b-strands.
Crystal soaking experiments with NHQ revealed that this
hydrophobic cavity within the PqsRCBD constitutes the AQ-ligand
binding site where the quinolone moiety is buried within the B
pocket, the alkyl chain extending into the surface crevice of the
CBDII A pocket. The PqsRCBD-NHQ complex is stabilised
entirely by hydrophobic interactions and no electrostatic interac-
tions are involved.
In P. aeruginosa reporter gene fusion assays, HHQ, PQS and
their C9 congeners (NHQ and C9-PQS) each have similar EC50s
(Figure 2; [23]) whereas the C11 congeners are inactive,
consistent with the space constraints noted from the crystal
structure. The importance of the amino acids observed to form the
PqsRCBD ligand binding site in the crystal structure was
investigated using site-directed mutagenesis. Of the 13 residues
Figure 6. Activation and inhibition of PqsR in P. aeruginosa by the 2-alkyl-4(3H)-quinazolinones. *EC50 determined in a P. aeruginosa
DpqsA miniCTX::pqsA’-lux strain; **IC50 determined in a P. aeruginosa wild type strain incorporating a miniCTX::pqsA’-lux fusion; – no activity;
`compounds exhibited growth inhibition; X compounds did not dissolve in MeOH at a workable concentration; 3-NH2-7Cl-PhOBn-QZN (46) is barely
soluble.
doi:10.1371/journal.ppat.1003508.g006
Figure 7. 3-NH2-7Cl-C9-QZN is a competitive inhibitor of PqsR. (A) PqsR activity as reflected by the maximum bioluminescence produced by
a miniCTX::pqsA’-lux fusion in a DpqsA mutant in the presence of 100 mM QZN (inset) and increasing concentrations of PQS; (B) Topology diagram of
the PqsRCBD ligand-binding site occupied by the QZN shown in stick (orange), with hydrogen bonds coloured purple; (C) Orientation of 4-quinolone
ring (right panel) and 7Cl-substituted QZN ring (left panel) within the PqsR ligand-binding pocket. The 7Cl is accommodated within a crevice forming
a hydrogen bond (dotted line) with Thr265 (left panel); (D) Superposed PqsRCBD-3-NH2-7Cl-C9-QZN and PqsR
CBD-NHQ structures with residues shown
as stick (orange and yellow respectively).
doi:10.1371/journal.ppat.1003508.g007
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mutated, all resulted in a major reduction in activity except for the
I186A mutation which is located at the edge of the A pocket and
retained ,44% activity. Interestingly the increased A pocket space
available as a consequence of the I186A replacement did not
increase the activity of the C9 (i.e. NHQ) or the C11 congeners of
HHQ (data not shown).
PQS and its biosynthetic precursor HHQ (as well as their C9
congeners) can both act as activating PqsR co-inducers. Using a P.
aeruginosa DpqsA DpqsH double mutant which cannot convert
exogenously supplied HHQ to PQS, we observed a,3-fold higher
induction of the pqsA promoter by PQS when compared with
HHQ (Figure 2). This is much lower than the 100-fold higher
induction reported by Xiao et al. [21] using a different P. aeruginosa
strain and reporter assay. PQS has also been reported to potentiate
the binding of recombinant PqsR in crude E. coli lysates to DNA
more effectively than HHQ [20], [21]. The greater efficiency of
PQS over HHQ may be a consequence of the increased H-
bonding opportunities with the Leu207 carbonyl afforded by the
presence of the 3-OH substituent. In this context it is perhaps
noteworthy that the L207A and L207E PqsR mutants are
significantly more responsive to PQS than to HHQ. Although
we were unable to obtain a structure for the PQS complex with
PqsRCBD, it is anticipated that as both the QZN and NHQ
PqsRCBD structures superpose accurately, that their similarity in
chemical structure with PQS will result in a similar binding.
Nevertheless, the primary advantage of introducing a 3-OH
substituent in HHQ is probably not enhancement of PqsR
activation but to confer additional functionalities since PQS,
unlike HHQ, induces outer membrane microvesicle formation
[24] and is a potent iron chelator [14].
LTTRs assemble into oligomers (tetramers, and in one case an
octamer) which is the functional DNA-binding structure affecting
DNA bending and the recruitment of RNA polymerase [41], [35],
[29]. The degree of DNA bending is determined by the presence
or absence of the co-inducer which causes a conformation change
in the LTTR resulting in a relaxation of the degree of DNA
bending [29], [42]. In the redox switch LTTR protein OxyR, the
reduced form is a tetramer and the activated, oxidised form
undergoes a conformational change in CBDII affecting a CBDI
interface within the tetramer. This is thought to position the DNA
binding domains appropriately for interaction with DNA and the
RNA polymerase [41]. The nature of the quaternary arrangement
formed by PqsR in complex with DNA and co-inducer has yet to
been elucidated. Progress towards this goal is hampered by the
inability to prepare full-length recombinant PqsR receptor
heterologously expressed in E. coli, an important goal for any
future studies in this area.
A comparison of the PqsRCBD structure with other LTTRs
reveals that the L1 loop in CBDII occupies the same region of the
topology as key residues required for co-inducer mediated
conformational changes [41], [35], [32]. In OxyR, the region
equivalent to the PqsR L1 loop switches conformation upon
oxidation or reduction and this is linked to a re-organisation of the
tetramer interface [41]. In TsaR and CatM, co-inducer interac-
tions and conformational switching are mediated by an a-helix
occupying the same position as the PqsR CBDII L1 loop [35],
[32]. Thus co-inducer affected changes in the region of the L1
loop may be the first steps on the pathway to activation of the
receptor and hence gene expression.
In our search for potent PqsR antagonists as novel therapeutics,
we focused on the QZN system since sterically it is closely related
to the natural AQ ligands. We systematically varied the nature and
size of the substituents at the 2 and 3 positions in the heterocyclic
ring as well as positions 6 and 7 in the carbocyclic ring of the QZN
structure to deliver a range of analogues with pharmacophores
that may have the desired stereo-electronic properties for
antagonist activity. Thus a total of 46 QZNs (Figure 6) were
synthesised, characterised (see supplemental Text S1) and assayed
for their agonist and antagonist activities in a whole P. aeruginosa
bacterial cell assay. The QZN analogues lacking substitution at C-
3 (Figure 6, 5–7) were inactive although their corresponding
AQs, HHQ and NHQ (Figure 2, 2 and 3) displayed strong
agonist activity. Substitution at C-3 with OH gave analogues 8 and
9 (Figure 6) which like the corresponding PQS and C9-PQS
(Figure 2, 1 and 4) were partial agonists. The 3-methoxy
derivatives 12 and 13 (Figure 6) were weak antagonists but were
totally devoid of agonist activity. Surprisingly, substitution with a
halogen in the C-7 position in the carbocyclic ring reversed the
activity and indeed 3-OMe-7F-C9-QZN (Figure 6, 15) had
potent agonist activity (EC50 2.2 mM) comparable with that of the
natural ligands. The introduction of a second halogen at C-6 has
the opposite effect and consequently 3-OMe-7F-C9-QZN
(Figure 6, 16) is a much weaker agonist.
The QZN compounds synthesized fell in two distinct groups
with 3-OH (and OMe) QZNs generally behaving as agonists and
the 3-NH2 QZNs as competitive antagonists in whole bacterial cell
assays of PqsR activity. Additionally, an alkyl chain of 9 carbons at
C-2 in the heterocyclic ring and a halogen at C-7 in the
carbocyclic ring are essential for optimum activity in both series. 3-
NH2-7Cl-C9-QZN (IC50 5.0 mM), 3-NH2-7F-C9-QZN (IC50
4.3 mM) and 3-NH2-6F,7F-C9-QZN (IC50 1.7 mM) were the most
potent antagonists discovered in our studies. Of these, 3-NH2-7Cl-
C9-QZN was shown to be an effective inhibitor of AQ signaling by
antagonizing AQ biosynthesis, virulence gene expression, pyocy-
anin production and biofilm development. Furthermore, the
preference for a halogen at C-7 over C-6 is clearly apparent from
the PqsRCBD/3-NH2-7Cl-C9-QZN complex structure
(Figure 7C) where additional H-bonding opportunities for the
7Cl substituent are afforded by the pocket formed by the Thr265.
Thus it is probable that 3-NH2-7Cl-C9-QZN binds more strongly
to the PqsRCBD than the native ligands via the strengthened
electrostatic interactions between 3-NH2 substituent, the water
molecule and Leu207 backbone carbonyl in conjunction with
additional H-bonding between the 7-Cl and Thr265. However this
will require experimental verification.
Remarkably, the simple replacement of the 3-OH with 3-NH2
in the 7Cl-substituted QZNs converts the compound from a
potent agonist to a potent antagonist (Figure 6, 11 and 23). The
importance of this small but significant finding is that the
replacement of the PQS 3-OH with 3-NH2 does not affect the
switch from agonist to antagonist (as both compounds are strong
agonists with similar EC50s (Figure 2; 1.9 mM compared with
Figure 8. 3-NH2-7Cl-C9-QZN inhibits AQ-dependent P. aeruginosa virulence factor production and biofilm development. (A)
expression of lecA in P. aeruginosa PAO1 is inhibited by 3-NH2-7Cl-C9-QZN as reflected by a lecA’-lux chromosomal reporter fusion; (B) production of
pyocyanin by P. aeruginosa PAO1 grown in the presence of 0, 50 or 100 mM 3-NH2-7Cl-C9-QZN and in a corresponding DpqsA mutant. The inhibition
of pyocyanin production by 3-NH2-7Cl-C9-QZN is observed as an absence of green pigmentation in culture supernatants (inset; numbers correspond
to columns); (C) Semi-quantitative analysis by LC-MS/MS of HHQ, NHQ, NQNO and PQS production by P. aeruginosa PAO1 grown in the absence or
presence of 200 mM 3-NH2-7Cl-C9-QZN. The DpqsA mutant was used as a negative control; (D) Biofilm development is reduced in P. aeruginosa by a
DpqsA mutation and following treatment of the wild type PAO1 strain with 3-NH2-7Cl-C9-QZN.
doi:10.1371/journal.ppat.1003508.g008
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0.4 mM). This indicates that for the QZNs compared with the
AQs, the stereo-electronic consequences of the additional QZN
ring nitrogen are profound in terms of PqsR activation.
In addition to the preliminary SAR studies for PQS agonists
[23], [43], PqsR antagonists have recently been described by Klein
et al. [44] and by Lu et al. [45]. The former identified substituted
benzamides lacking extended alkyl chains which bind to the
PqsRCBD and exhibit relatively weak agonist or antagonist
activities by using (6)-trans-U50488 as a template for rational
design since this k-opioid receptor agonist was reported to
stimulate pqsA transcription [46]. The biological evaluation of
these compounds and those of Lu et al. [45] have mostly been
undertaken using a heterologous E. coli-based PqsR-dependent
transcriptional reporter which is more sensitive to PQS than P.
aeruginosa [23], [43]) probably as a consequence of the numerous
efflux pumps present in the latter. HHQ analogues with electron-
withdrawing C6 substituents (nitrile (–CN), triofluoromethyl (–
CF3) and nitro (–NO2)) were potent antagonists in E. coli whole cell
assays with EC50s in the nanomolar range [45]. However, at the
concentrations tested, they failed to reduce PQS production in P.
aeruginosa although pyocyanin levels were lower after treatment
with the 6-CF3 analogue. Interestingly, the 7-CF3-substituted
HHQ, in contrast to the 6-CF3 analogue, was devoid of antagonist
activity and retained agonist activity at about 50% that of HHQ
[45]. In the E. coli-based assay, PQS analogues with Cl
substitutions at 5, 6, 7 or 8 all exhibited similar activities to PQS
[43]. However, in P. aeruginosa, 7-Cl-PQS is ,1356more potent
than PQS (Figure 2), a finding consistent with the PqsRCBD/3-
NH2-7Cl-C9-QZN complex structure which revealed that a 7-Cl
substituent can occupy a pocket and form an H-bond with the side
chain of Thr265.
Competitive PqsR antagonists such as 3-NH2-7Cl-C9-QZN
bind within the PqsRCBD ligand binding pocket in the same
orientation as agonists such as NHQ and form additional
hydrogen bonds to the side chain OH of Thr265 and the main
chain carbonyl of Leu207. Since LTTR agonists stimulate
transcription of target genes through changes in the orientation
of the DNA and ligand-binding domains [32] this would suggest
that the binding of 3-NH2-7Cl-C9-QZN, although likely to be
tighter than an agonist, is not productive and either maintains the
PqsR conformation in the same state as the unbound protein or
drives the formation of a different, but inactive, conformation. The
latter mechanism has been reported for an antagonist that binds in
place of the native N-acylhomoserine lactone ligand to the LuxR
family protein CviR and forces the transcriptional regulator to
adopt a conformation incompatible with high affinity DNA
operator binding [47]. Here we have found that superposition of
the PqsRCBD-3-NH2-7Cl-C9-QZN and PqsR
CBD-NHQ complex-
es results in subtle changes which tilt the bicyclic ring of the QZN
relative to that of NHQ so the QZN interaction is not productive
for PqsR activation.
Taken together this work has increased our knowledge of the
molecular recognition of ligands by PqsR, demonstrated how the
simple and subtle exchange of two isosteres (OH for NH2) within a
co-inducer molecule can effectively switch virulence gene expres-
sion on or off and provided a template structure for the
development of QZNs as novel therapeutics which control
infection through attenuation of P. aeruginosa virulence.
Materials and Methods
Bacterial Strains and Growth Conditions
The E. coli and P. aeruginosa strains used in this study (Table S1)
were grown in Lysogeny broth (LB) at 37uC. For AQ quantifi-
cation, P. aeruginosa was grown in minimal medium [48]. When
required for plasmid maintenance in E. coli (pET28a derivatives)
or P. aeruginosa (pME6032 derivatives), kanamycin (50 mg/ml) or
tetracycline (125 mg/ml) were respectively added to the growth
medium.
Mutant Construction
The P. aeruginosa DpqsR in-frame deletion mutant and the triple
DpqsA DpqsH DpqsR mutant were constructed in the PAO1 parent
and DpqsA DpqsH mutant [14] respectively using the pDM4DpqsR
plasmid. The upstream and downstream fragments of pqsR were
amplified by PCR from PAO1 chromosomal DNA using the
primers pairs FWpqsRUp-RVpqsRUp and FWpqsRDown-
RVpqsRDown, respectively (Table S2), introduced into pDM4
[49] and the resulting DpqsR mutants obtained by allelic exchange
[50]. The pqsA promoter fused to the luxCDABE reporter operon
was introduced into both the DpqsR and DpqsA DpqsH DpqsR
mutants using the miniCTXpqsA-lux plasmid as described previ-
ously [23].
For complementation assays, the pqsR gene with or without a C-
terminus 6xHis coding sequence (pqsR-6H) was amplified by PCR
from chromosomal DNA with primer pairs FWpqsR-RVpqsR or
FWpqsR-RVpqsR-6H, respectively (Table S2), and cloned by
EcoRI-SacI digestion into pME6032 [51]. Site-directed mutations
were generated in pqsR-6H using the splicing by overlap extension
PCR method [52]. Briefly, in the first step two distinct PCRs
(PCR-1 and PCR-2) were carried out for each pqsR-6his derivative
mutant, using chromosomal P. aeruginosa DNA as a template. Each
PCR-1 was performed with the forward primer FWpqsR and with
a mutagenic reverse primer carrying the mutation in the desired
codon (Table S2). Each PCR-2 was performed with a mutagenic
forward primer complementary to the reverse primer utilized in
the corresponding PCR-1 (Table S2) and with primer RVpqsR-
6H. In the second PCR step products obtained from PCR-1 and
PCR-2 for each mutation were spliced together using the FWpqsR
and RVpqsR-6H primers. The mutated pqsR-6H variants were
cloned by EcoRI/SacI digestion in pME6032 and verified by
DNA sequencing. The expression of each of the PqsR variants was
confirmed by Western blot analysis using a mouse anti-6xHis
antibody (1:1,000; Sigma-Aldrich, St. Louis, MO, USA).
Protein Expression, Purification and Crystallization
For overexpression of the PqsRCBD, the regions corresponding
to the PqsR C94-332 and PqsR C94-294 CBD were amplified by
PCR and cloned into pET28a. The recombinant plasmids were
introduced by transformation into E. coli Rosetta 2 (DE3) and
grown at 37uC to an OD600 0.8 prior to induction with IPTG
(1 mM) at 20uC for 16 h. After harvesting by centrifugation, the
bacteria were lysed by sonication, centrifuged and filtered to
remove cellular debris prior to nickel affinity column purification
and elution with an imidazole gradient (0 to 1 M). The 6xHis tag
which included the thrombin cleavage sequence was removed
from the PqsRCBD proteins using thrombin (Novagen; enzyme/
substrate ratio 1:1000 for 24 h). Final purification was achieved by
gel filtration using a Superdex 75 16/60 gel filtration column, with
a mobile phase consisting of 20 mM Tris-HCl, 150 mM NaCl,
pH 7.4. Both constructs yielded approximately 25 mg PqsRCBD/
litre of culture as confirmed by SDS-PAGE. The same strategy
was used to obtain the PqsR94-332 selenomethionine-labelled
protein after transforming the E. coli methionine auxotroph strain
B834 (DE3) with pPqsR94-332 and growing the recombinant strain
in selenomethionine medium. A protein concentration of 25 mg/
ml was used for 96-well crystal screening (Qiagen kits) and crystals
were obtained for PqsR94-332 and from several conditions using
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only the MPD suite (Qiagen) after 24 h at 19uC. Optimized
conditions in 24-well sitting drop plates containing a reservoir of
100 mM trisodium citrate pH 6.0, 200 mM ammonium acetate
and 3% v/v MPD and identical crystals grew with the shortened
PqsR94-309 construct.
Analytical gel filtration was performed with a Superdex 75 10/
300 column equilibrated with running buffer of 20 mM Tris-HCl,
150 mM NaCl, pH 7.4. The standards used were ovalbumin
(43 kDa), carbonic anhydrase (29 kDa) and ribonuclease A
(13.7 kDa).
Data Collection and PqsRCBD Structure Determination
Crystals were transferred to a solution with cryoprotectant of
25% MPD and cryo-cooled for collection of diffraction data. The
detailed method for PqsRCBD-MPD structure determination is
outlined in Text S1. Native and derivative datasets were collected
at beamline IO4 of the Diamond synchrotron and data was
processed using XDS and reduced with the CCP4 suite (statistics
are shown in Table 1 together with the description of the SIRAS
structure determination for the PqsRCBD-MPD structure). PqsR
ligands were dissolved in 100% MPD or in a 1:1 mixture of MPD
and isopropanol to give a concentration of 20 mM. When added
to recombinant PqsRCBD even low concentrations of these
compounds resulted in heavy precipitation. The soaking of
PqsR94-309 crystals was carried out for 24–48 h with ligands at
5–10 mM. Soaking experiments with HHQ, NHQ, PQS, C9-
PQS and shorter chain analogues were carried out and in each
case crystals were transferred to a solution with cryoprotectant of
25% MPD and cryo-cooled for collection of diffraction data.
Datasets were collected at beamline IO2 of the Diamond
synchrotron and data were processed using XDS and reduced
with the CCP4 suite (Table 1). Rigid body refinement
(REFMAC) was carried out to adjust for small changes in cell
dimension and 2Fo-Fc and Fo-Fc electron density maps were
calculated using the CCP4 suite. Additional electron density was
observed for NHQ and 3-NH2-7Cl-C9-QZN soaked crystals.
Model building was carried out using COOT and refinement with
REFMAC.
AQ and QZN Synthesis
The AQs and QZNs listed in Figures 2 and 6 were
synthesised and characterised as described in the supplemental
information provided in Text S1.
Bioluminescence Reporter Gene Fusion Assays
The impact of the AQs and QZNs on PqsR-dependent gene
expression in P. aeruginosa was evaluated using lux-based pqsA, lecA
and phzA1 promoter fusions (Table S1) in 96-well microtiter
plates as described before [14],[23]. Bioluminescence and
bacterial growth were quantified using a combined luminometer-
spectrometer (Tecan GENios Pro). Where required, AQs or QZNs
were added to reporter strains and EC50 or IC50 values were
extracted from the sigmoidal dose–response curves obtained using
Prism2 (Graphpad, San Diego, USA).
AQ, Pyocyanin and Biofilm Analysis
The impact of 3-NH2-7Cl-C9-QZN on (a) AQ production was
assayed by LC MS/MS after extracting bacterial cultures with
acidified ethyl acetate [11]; (b) pyocyanin was quantified
spectrophotometrically [16] and (c) biofilm development was
examined using a Bioflux 200 microfluidics device (Fluxion
Biosciences; in conjunction with GFP-labelled P. aeruginosa strains,
[53]). All assays were performed in triplicate at least twice.
Supporting Information
Figure S1 (A) Gel filtration chromatogram of PqsRCBD (residues
94-332). Absorbance elution profiles are shown PqsRCBD in blue
overlapped with the elution profiles of protein standards (red)
using a Superdex 75 10/300 analytical column. The standards
include I - ovalbumin (43 kDa), II - carbonic anhydrase (29 kDa)
and III - ribonuclease A (13.7 kDa). (B) The PqsRCBD tetrameric
arrangement observed in the crystal structure shown as topology
with MPD shown as spheres. (C) A close up view of the PqsRCBD
tetramer interface shown as topology. Two views are shown
related by a 180 degree rotation with hydrogen bonding
interactions highlighted as dotted lines (orange) and key residues
shown in stick. (D) End view of the interface shown in (C).
(PDF)
Figure S2 Electron density maps are shown for bound ligands
displayed within a 2 A˚ radius. (A) Left panel shows the final refined
2.7 A˚ electron density map (blue) with SigmaA m2Fo-DFc
coefficients and phases c of the PqsR-MPD structure contoured
at 1.0 r.m.s (REFMAC, CCP4). The modelled MPD molecules are
shown as stick and the figure was generated using PyMOL. The
middle panel shows the same calculation with the atoms of the
MPD excluded (simple omit map). The far right panel is calculated
in the absence of any atoms from the ligand with the remaining
coordinates utilised in a simulated annealing (SA) combined omit
map protocol. The map was displayed in COOT used to generate
the figure and contoured at 1.2 r.m.s. (B) Left panel shows the final
refined 3.1 A˚ electron density map (blue) with SigmaA m2Fo-DFc
coefficients and phases c of the PqsR-NHQ structure contoured at
1.0 r.m.s (REFMAC). The modelled NHQ molecule is shown as
stick and the figure was generated using PyMOL. The middle
panel shows the same calculation with the atoms of the NHQ
excluded (omit map). The far right panel is the phenix SA omit
calculation described in (A) with NHQ atoms omitted and
contoured at 1.2 r.m.s. (C) Left panel shows the final refined
3.1 A˚ electron density map (blue) with SigmaA m2Fo-DFc co-
efficients and phases c of the PqsR-3NH2-7Cl-C9QZN (QZN)
structure contoured at 1.0 r.m.s (REFMAC). The modelled QZN
molecule is shown as stick and the figure was generated using
PyMOL. The right panel shows the phenix SA omit calculation as
in (A) with the atoms of the QZN excluded.
(PDF)
Figure S3 Unique dimer organisation of PqsR. Cartoon
diagrams of the central dimer organisation for LTTRs PqsR,
OxyR (pdb: 1I69), BenM (pdb: 2F78) and TsaR (pdb: 3FXQ). b-
strands are colored magenta and a-helices in cyan. b-strands
involved in the hinge region are indicated by a blue arrow showing
the centrally located hinge regions in PqsR compared to the
peripheral location of hinge regions on OxyR, BenM and TsaR.
(PDF)
Table S1 Strains and plasmids used in this study.
(PDF)
Table S2 Oligonucleotides used in this study.
(PDF)
Text S1 Supplemental Materials and Methods and 1H NMR
spectra.
(PDF)
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